/Companies

Metalead

1 known investors

Find your way into Metalead

Sign up to see every warm intro you have to Metalead

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Metalead team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.

Founders & leadership

MSMichal Shoshan
Michal ShoshanFounder and CEOMichal Shoshan is founder and CEO of metaLead Therapeutics AG, a University of Zurich spin-off focused on metal-centered medicine. He holds background in medicinal inorganic chemistry and chemical biology.

Investors · 1

Frequently asked questions

What does Metalead do?
metaLead develops medications for treating metal-related diseases using chelation therapy, targeting improved patient quality of life. The company aims to establish its therapies as first-line treatments for various conditions.
Who founded Metalead?
Metalead was founded by Michal Shoshan.
Who are Metalead's investors?
Metalead's investors include Kickfund.